Highlights
NASDAQ: DNLI       Denali Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
25.45   +0.21 (0.83%)  24.08 - 25.73  314,200

Overview

 
Avg Volume (4 weeks):759,178
4 Weeks Range:23.25 - 27.71
4 Weeks Price Volatility (%):
49.33%
52 Weeks Range:12.39 - 30.41
52 Weeks Price Volatility (%):
72.48%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Denali Therapeutics Inc is a biotechnology company which is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include LRRK2 Inhibitor Program which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle) and others.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2452  5804  513  138 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ZOM 0.168-0.057 
 GNUS 3.55+1.24 
 NIO 9.38+1.47 
 LK 1.38-1.62 
 SOLO 3.13+0.80 
 WKHS 20.91+1.73 
 AAL 12.50-0.31 
 JOB 1.50+0.986 
 SQQQ 7.14-0.15 
 GE 6.82+0.08 
Partners & Brokers